Corcept Therapeutics Incorporated (CORT) — the peer cohort
As of 2026-10-15 — scores re-bake nightly. Cohort = shared Closelooknet index membership first, then sector. Diary readings, not advice.
Corcept Therapeutics Incorporated ranks 7 of 7 in its cohort on the Closelooknet composite (57/100) — the cohort is led by Halozyme Therapeutics Inc at 75/100.
| Name | Composite | Momentum | Quality | Valuation | Signal | Off 52w high |
|---|---|---|---|---|---|---|
| CORT Corcept Therapeutics Incorporated | 57 | 92 | 48 | 22 | info | 10.3% |
| HALO Halozyme Therapeutics Inc | 75 | 98 | 94 | 47 | ok | 0.7% |
| ARGX.BR Argen-X | 64 | 64 | 75 | 28 | info | 18% |
| ONC BeiGene, Ltd. | 64 | 84 | 63 | 30 | ok | 2.9% |
| ARGX argenx NV ADR | 62 | 56 | 74 | 28 | info | 21.1% |
| UCB.BR UCB SA | 61 | 20 | 70 | 57 | warn | 28.5% |
| KRYS Krystal Biotech Inc | 60 | 64 | 85 | 16 | info | 13.7% |
Scores are relative readings across the Closelooknet coverage universe — methodology in the company-scoring explainer. Signal lights come from the nightly signal board.
FAQ · from the current data · as of 2026-10-15
Quick answers
Who are Corcept Therapeutics Incorporated's peers in the Closelooknet universe?
The cohort is drawn from shared Closelooknet index membership first, then sector: Halozyme Therapeutics Inc (HALO), Argen-X (ARGX.BR), BeiGene, Ltd. (ONC), argenx NV ADR (ARGX), UCB SA (UCB.BR), Krystal Biotech Inc (KRYS).
How does CORT score against its peers?
Corcept Therapeutics Incorporated's composite reads 57/100, ranking 7 of 7 in its cohort as of 2026-10-15; the cohort's highest composite is Halozyme Therapeutics Inc at 75/100. Closelooknet scores are research diary readings, not ratings or advice.
Mentioned on Closelooknet
Where CORT appears in the diary — 1 piece, newest first. Every link is our own writing.
Go deeper
Dailies
- A chart pick published at 95.10 this morning trades 107.92 by midday — Robinhood's triangle breaks up through the 100 shelf — as the CAC snaps seven straight red sessions and Bitcoin adds another six percent above 77,000
Barchart's large-cap 52-week new-high list, as of 11:59 CDT, carries 31 names and reads like the ex-tech thesis printed as breadth: twelve are health care, biotech or pharma — ARGX, BDX, BIO, CORT, HALO, MRK, REGN, RVTY, THC, TVTX, TXG…
Related in the Closelooknet universe
then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- HALO Halozyme Therapeutics Incindustry
- ARGX.BR Argen-Xindustry
- ONC BeiGene, Ltd.industry
- ARGX argenx NV ADRindustry
- UCB.BR UCB SAindustry
- KRYS Krystal Biotech Incindustry
- MRNA Moderna Incindustry
- DNA Ginkgo Bioworks Holdingsindustry
- ONT.L Oxford Nanopore Technologies Ltdindustry
- CAI Caris Life Sciences, Inc. Common Stockindustry
- RXRX Recursion Pharmaceuticals Incindustry
- EXEL Exelixis Incindustry
- RPRX Royalty Pharma Plcindustry
- TECH Bio-Techne Corpindustry
- MRVI Maravai Lifesciences Holdings Incindustry
- TWST Twist Bioscience Corpindustry
- BION.SW BB Biotech AGindustry
- INCY Incyte Corporationindustry
- JAZZ Jazz Pharmaceuticals PLCindustry
- GNS.L Genus PLCindustry